Updated Jul 16, 2026
snyderman nancy lynn MD has filed 1 SEC Form 4 filing across 1 company in the last 90 days.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-05-23 | ALKS | Alkermes plc. | F — Tax withholding / forfeiture | 1.5K | $36.95 | $55K |
| 2026-05-23 | ALKS | Alkermes plc. | M — Option exercise | 6.1K | — | |
| 2024-11-15 | AXNX | Axonics, Inc. | D — Derivative transaction | 14.9K | $71.00 | $1.06M |
| 2024-11-12 | AXNX | Axonics, Inc. | G — Bona-fide gift | 5.0K | $0.00 |
snyderman nancy lynn MD is a corporate insider — currently tracked as Director of Alkermes plc. (ALKS). InsiderAlpha tracks every SEC Form 4 filing in real time.
1 primary Form 4 filings in the last 90 days, covering 1 company.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live snyderman nancy lynn MD profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.